Public awareness of atrial fibrillation and its consequences is increasing. In the current environment, this is driven largely by promotion of individual therapies. This editorial discusses the need for greater depth in the discussion of the disease state, its progression and economic consequences as well as the risk of death and disability. The adverse effects of therapies on cardiovascular outcomes is a major need in public education. New initiatives should address these important new insights and needs.
Credits: Sanjeev Saksena, MD FHRS FACC FAHA FESC FRSM